VR Logo

SOPHiA GENETICS SA (SOPH) download report


Healthcare | Health Services

SOPHiA GENETICS SA (SOPH) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.

IPO Date: 23-Jul-2021

Co-Founder, CEO & Director: Dr. Jurgi Camblong M.B.A., Ph.D.

Sr. VP & CFO: Mr. Ross Jordan Muken B.Sc.

Listing: NASDAQ: SOPH

Country: Switzerland

Headquarters: Saint-Sulpice,

Website: https://www.sophiagenetics.com

Key Facts

Market cap: $217.31 Mln

Revenue (TTM): $42.34 Mln

Earnings (TTM): $-86.49 Mln

Cash: $243.52 Mln

Total Debt: $0.00 Mln

Insider's Holding: 4.88%

Liquidity: Low

52 Week range: $2.16 - 19.80

Shares outstanding: 63,915,200

Stock Performance

Time Period SOPHiA GENETICS SA (SOPH) S&P BSE Healthcare S&P Small-Cap 600
YTD-75.07-17.34-19.67
1 month-18.45-3.61-9.84
3 months-51.92-10.54-15.05
1 Year---14.59-18.10
3 Years--18.895.71
5 Years--9.135.53
10 Years--12.3510.04
As on 29-Jun-2022